CRISPR Technologies White Spaces Analysis

Table Of Contents

Excel Deliverable
1. Research Notes

2. Summary Dashboard
A. Overall Intellectual Property Landscape
B Key Prior Art Search Expressions
C. Key Trends related to Patent Applications
D. Key Trends related to Granted Patents
E. Claims Analysis
F. Key CPC Symbols 
G. Key Applicants

3. Overall Intellectual Property Landscape Dataset

4. Prior Art Search Expressions (Keyword Analysis)

5. Patent Applications Dataset 

6. Granted Patents Dataset

7. Claims Analysis

8. Key Applicants Analysis

9. CPC Analysis

10. Appendix I: Pivot Tables

11. Appendix II: Country / Geography Codes

12. Appendix III: Innovation Categories

PowerPoint Deliverable

1. Context  

2. Project Approach

3. Project Objectives 

4. Executive Summary

5. CRISPR Technologies
5.1. Overview
5.2. Key Historical Milestones
5.3. Mechanism of Action
5.4. Challenges and Solutions
5.5. Key Areas of Applications

6. Overall Intellectual Property Landscape
6.1. Overview
6.2. Analysis of Published IP Documents
6.3. Insights from Patent Applications
6.4. Insights from Granted Patents

7. Key Prior Art Search Expressions
7.1. Overview
7.2. Analysis of Prior Art Search Expressions

8. Intellectual Property Valuation Analysis 
8.1. Valuation Overview
8.2. Analysis of Individual Value Ranks
8.2.1. Rank 1 IP Documents
8.2.2. Rank 2 IP Documents
8.2.3. Rank 3 IP Documents
8.2.4. Rank 4 IP Documents
8.2.5. Rank 5 IP Documents
8.3. Concluding Remarks

9. Analysis of Patent Applications
9.1. Overview
9.2. Relative Valuation of Patent Applications
9.3. Patentability and Freedom-to-Operate

10. Analysis of Granted Patents
10.1. Overview
10.2. Relative Valuation of Grated Patents
10.3. Patentability and Freedom-to-Operate
10.4. Analysis of Patent Claims

11. Key Applicants
11.1. Overview
11.2. Analysis of Key Applicants
11.2.1. Massachusetts Institute of Technology
11.2.2. University of California
11.2.3. Harvard University
11.2.4. CRISPR Therapeutics
11.2.5. Editas Medicine
11.2.6. Regeneron Pharmaceuticals
11.2.7. Inscripta 
11.2.8. Intellia Therapeutics
11.2.9. ToolGen 
11.2.10. Caribou Biosciences
11.2.11. Beam Therapeutics
11.2.12. Bayer 
11.2.13. Novartis 
11.2.14. Sigma-Aldrich
11.2.15. SNIPR Biome

12. Pockets of Innovation and White Spaces
12.1. Overview
12.2. Pockets of Innovation
12.3. White Spaces
12.4. Concluding Remarks

13. Future Outlook 
13.1. Clinical Research
13.2. Contemporary Sentiments & Expert Opinions
13.3. Anticipated Future Developments & Trends

14. Appendices

List of Companies

Please reach out to our team for the details.

Source: www.nature.com/articles/s41392-019-0089-y